EcoDrugPlus

Estrogen Receptor Beta-Like

Ensembl ID : ENSPNAG00000018028
Gene Symbol: LOC108412120
3 Cross references
198 Possible Orthologues:

Estrogen Receptor-Like

Ensembl ID : ENSPNAG00000012604
Gene Symbol: LOC108424497
3 Cross references
215 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSPNAG00000027097
Gene Symbol: ESRRG
3 Cross references
153 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPNAG00000014209
Gene Symbol: XPO1
3 Cross references
222 Possible Orthologues:

Exportin 1

Ensembl ID : ENSPNAG00000008916
Gene Symbol: XPO1
3 Cross references
157 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSPNAG00000018431
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSPNAG00000007613
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSPNAG00000024571
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:

Fibroblast Growth Factor Receptor 1-A

Ensembl ID : ENSPNAG00000020161
Gene Symbol: LOC108426697
3 Cross references
209 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSPNAG00000008635
Gene Symbol: FGFR2
3 Cross references
219 Possible Orthologues:

Fibroblast Growth Factor Receptor 3

Ensembl ID : ENSPNAG00000016220
Gene Symbol: FGFR3
3 Cross references
193 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSPNAG00000025453
Gene Symbol: FLT1
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).